(Q34286115)

1 August 2017

1 reference

title

Protein misfolding and disease; protein refolding and therapy (English)

1 reference

1 August 2017

1 reference

Soto C

1

1 reference

PubMed ID

11412858

1 August 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

1 August 2017

1 reference

1 August 2017

498

1 reference

1 August 2017

204-207

1 reference

1 August 2017

2-3

1 reference

1 August 2017

Conformational disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Alternative conformations of amyloidogenic proteins govern their behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Defective protein folding as a basis of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Conformational changes and disease--serpins, prions and Alzheimer's.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Late-onset neurodegenerative diseases--the role of protein insolubility

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Amyloidosis: a review of recent diagnostic and therapeutic developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Aggregates in neurodegenerative disease: crowds and power?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

The genetics of the amyloidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Amyloid beta-protein and the genetics of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Genetic neurodegenerative diseases: the human illness and transgenic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

What transgenic mice tell us about neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene. Pathological and immunohistochemical similarity to human familial amyloidotic polyneuropathy, type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Alzheimer disease: mouse models pave the way for therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Single and multiple transgenic mice as models for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Transgenic models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Spontaneous neurodegeneration in transgenic mice with mutant prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Kinetic theory of fibrillogenesis of amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Pathologic conformations of prion proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

In vivo reversal of amyloid-beta lesions in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Examination of the Structure of the Transthyretin Amyloid Fibril by Image Reconstruction from Electron Micrographs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

7 January 2021

Diagnosing amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

The use of transgenic mice in the investigation of transmissible spongiform encephalopathies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Recent work on Alzheimer's disease transgenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Defective protein folding as a cause of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

The value of transgenic models for the study of neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902486-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-5793(01)02486-3

1 reference

1 August 2017

1 reference

PubMed ID

11412858